𝔖 Bobbio Scriptorium

✦ LIBER ✦

Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia

✍ Scribed by Jándula, B M; Nomdedeu, J; Marín, P; Vivancos, P

Book ID: 110012870
Publisher: Nature Publishing Group
Year: 2001
Tongue: English
Weight: 136 KB
Volume: 27
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1702706

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serial minimal residual disease (MRD) an

Serial minimal residual disease (MRD) analysis as a predictor of response duration in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) during imatinib treatment

✍ Scheuring, U J; Pfeifer, H; Wassmann, B; Brück, P; Gehrke, B; Petershofen, E K; 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

Primers and protocols for standardized d

Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemia

✍ Pongers-Willemse, MJ; Seriu, T; Stolz, F; d’Aniello, E; Gameiro, P; Pisa, P; Gon 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 137 KB